共同药业：回购方案已实施完毕

Core Viewpoint - On October 17, 2025, the company announced the completion of its share repurchase plan, having repurchased a total of 1,069,600 shares, which represents 0.9278% of its current total share capital [1] Summary by Sections - Share Repurchase Announcement - The company initiated its share repurchase program on March 25, 2025, through a special securities account via centralized bidding [1] - The total number of shares repurchased is 1,069,600 [1] - This repurchase accounts for 0.9278% of the company's total share capital as of the announcement date [1]